한글목차

뇌동맥류 동향과 예측

세계 뇌동맥류 시장은 2024년부터 2030년까지 연평균 8.8%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 전 세계적으로 신경 질환의 발생이 증가하고 고령화 인구가 급증하고 있다는 점입니다. 세계 뇌동맥류 시장의 미래는 병원, 재택의료, 전문센터 시장에서 기회가 있어 유망한 것으로 평가됩니다.

Lucintel은 미파열 동맥류가 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

종합적인 인프라, 응급 시설, 신경외과 전문 지식의 존재로 인해 병원은 이 시장에서 가장 큰 부문으로 남아있을 것입니다.

북미는 뇌손상 유병률 증가, 높은 의료비 및 보험 적용률로 인해 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

자주 묻는 질문

Q1. 시장 성장 예측은?

A1. 세계 뇌동맥류 시장은 2024년부터 2030년까지 연평균 8.8%의 성장률을 보일 것으로 예상됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은 무엇인가?

A2. 이 시장의 주요 촉진요인은 전 세계적으로 신경 질환의 발생과 고령화 인구의 급격한 증가입니다.

Q3. 시장의 주요 부문은?

A3. 뇌동맥류 시장의 미래는 병원, 재택의료, 전문센터 시장에서의 기회로 인해 유망합니다.

Q4. 시장의 주요 기업은?

A4. 뇌동맥류의 주요 기업은 다음과 같습니다.

• Pfizer
• F. Hoffmann-La Roche
• Mylan
• Fresenius Kabi
• Hikma Pharmaceuticals
• Novartis
• Teva Pharmaceutical Industries
• Heyer Medical
• Smiths Medical
• Johnson & Johnson Services

Q5. 향후 가장 큰 시장 부문은?

A5. Lucintel은 미파열 동맥류가 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

Q6. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은 어디인가?

A6. 북미는 뇌손상 유병률 증가, 높은 의료비 및 보험 적용률로 인해 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

Q7. 보고서 사용자 정의가 가능한가?

A7. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 뇌동맥류 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 뇌동맥류 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 뇌동맥류 시장(유형별)
  • 파열된 동맥류
  • 누출된 동맥류
  • 미파열 동맥류
  • 기타
• 세계의 뇌동맥류 시장(치료별)
  • 수술
  • 투약 치료
  • 기타
• 투여 경로별 세계의 뇌동맥류 시장
  • 경구
  • 비경구
  • 기타
• 최종 용도별 세계의 뇌동맥류 시장
  • 병원
  • 재택의료
  • 전문 센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 뇌동맥류 시장
• 북미의 뇌동맥류 시장
• 유럽의 뇌동맥류 시장
• 아시아태평양의 뇌동맥류 시장
• 기타 지역 뇌동맥류 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 뇌동맥류 시장의 유형별 성장 기회
  • 세계의 뇌동맥류 시장의 치료 성장 기회
  • 투여 경로별 세계의 뇌동맥류 시장 성장 기회
  • 최종 용도별 세계의 뇌동맥류 시장 성장 기회
  • 지역별 세계의 뇌동맥류 시장 성장 기회
• 세계의 뇌동맥류 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 뇌동맥류 시장 능력 확대
  • 세계의 뇌동맥류 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Pfizer
• F. Hoffmann-La Roche
• Mylan
• Fresenius Kabi
• Hikma Pharmaceuticals
• Novartis
• Teva Pharmaceutical Industries
• HEYER Medical
• Smiths Medical
• Johnson & Johnson Services

영문목차

Brain Aneurysm Trends and Forecast

The future of the global brain aneurysm market looks promising with opportunities in the hospitals, homecare, and specialty centers markets. The global brain aneurysm market is expected to grow with a CAGR of 8.8% from 2024 to 2030. The major drivers for this market are the escalating occurrence of neurological disorders on a global scale and the surge in the aging population.

Lucintel forecasts that unruptured aneurysms will remain the largest segment over the forecast period.

Within this market, hospitals will remain the largest segment due to presence of comprehensive infrastructure, emergency facilities, and neurosurgical expertise.

North America will remain the largest region over the forecast period due to increasing prevalence of brain injuries and high healthcare spending and insurance coverage in the region.

Emerging Trends in the Brain Aneurysm Market

The brain aneurysm market is undergoing revolutionary changes driven by emerging technology trends, treatment modalities, and health service provision. These shifts are redesigning the sector through better diagnosis, improved treatment results and more accessible care. This has led to a situation where cutting-edge technologies are being integrated into healthcare systems around the world, personalized medicine is becoming mainstream and early intervention is given primary attention.

• Technological Advancements: The use of advanced imaging technology like 3D angiography or AI-guided diagnostics is transforming how we detect and treat brain aneurysms. These facilitate realty earlier diagnostic process as well as accurate prediction of what will happen to patients thus enabling early response system for optimal patient outcomes. Traditional methods might miss out on some aneurysms which can be identified using artificial intelligence (AI) algorithms that analyze images from various sources such as CT scans or MRI machines before making predictions about the chances it could burst open in future lives. Thereby this trend allows for highly individualized curative approaches while minimizing complications during disease management hence boosting overall efficacy of managing brain aneurysms at large.
• Minimally Invasive Procedures: Significantly, the shift to minimally invasive therapies is changing how patients are treated for brain aneurysms. Endovascular coiling and flow diversion techniques such as coil embolization or endovascular stent placement have become more popular, offering safer alternatives to conventional surgery that involves opening the skull. These procedures help decrease recovery time, minimize surgical risks, and produce better long-term outcomes. The introduction of new equipment like softer coils and more flexible stents has also improved the efficiency of these treatments. Consequently, an increasing number of patients are choosing minimally invasive options thus driving demand for these sophisticated surgical procedures.
• Personalized Medicine: Genetic testing and biomarker analysis have become important in the treatment planning process in personalized medicine which is becoming a key trend in the Brain Aneurysm market. Medical professionals can offer more targeted care based on their understanding of genetic factors that contribute towards formation and rupture of aneurysms thereby improving patient outcomes while reducing adverse events risks. This concept facilitates accurate risk stratification that enables early intervention among high-risk groups. Personalized medicine is expected to be increasingly significant in managing brain aneurysms moving forward.
• Increased Public Awareness: Public awareness campaigns against brain aneurysms are increasingly getting intense as they have led to faster diagnosis and intervention. Such moves are usually initiated by health care institutions and disease advocacy groups, which intend to enlighten the general public about signs and hazards of aneurysm. Such knowledge has been responsible for enabling more people seek medical attention when the first symptoms become apparent, something that is key in preventing rupture and increasing survival rates. Moreover, growth in awareness is also driving demand for screening programs while expanding Brain Aneurysm market.

Technology change, rise of minimally invasive procedures, personalized medicine adoption, improved public information and regulatory assistance has resulted in a tremendous transformation of the Brain Aneurysm market. These developments are jointly changing diagnosis, treatment and management of brain aneurysms leading to better patients' results and improved health care provision. With these emerging trends, it is expected that more innovations will be seen in this market which will significantly improve the quality of patient care across the globe.

Recent Developments in the Brain Aneurysm Market

Revolutionary changes have hit the brain aneurysm market due to technological advancements, better diagnosis tools and development of new treatment options. These developments are increasing patient outcomes as well as expanding the scope of care for brain aneurysms.

• Sophisticated Imaging Technologies: Recent advancements in imaging technologies, for example 3D angiography and MRI, have resulted to significantly improved detection and diagnosis of brain aneurysms. These instruments give clear images of blood vessels in the brain making it possible to detect earlier and more accurately assess the size or location of aneurysms. Use of AI on these pictures further enhances accuracy in diagnosis by helping healthcare providers identify cases that could be missed using traditional methods. This advancement leads to earlier more effective interventions thus improving patients' outcome while decreasing risks related to rupture of such aneurisms.
• Minimally invasive endovascular procedures: In the market for brain aneurysm, there has been a major shift towards minimally invasive endovascular procedures. These are alternatives to traditional open surgery such as endovascular coiling and flow diversion that reduce the risk of complications and shorten recovery time. By moving catheters through blood vessels to treat aneurysms from within, these operations are less invasive than others thus they are safe for patients. Moreover, the devices became more flexible which led to their mass adoption and thus improved treatment of brain aneurysms.
• AI and Machine Learning in Diagnostics: AI and machine learning have played an increasingly important role in diagnosing and managing brain aneurysms. Through this technology, big data sets consisting of imaging studies have been analyzed helping identify patterns that predict whether or not an aneurysm may rupture. Personalized therapy programs can also be designed using AI - driven tools by examining patient-specific information which will then recommend the most effective treatment approaches. The accuracy of detecting vascular lesions increases with integration of AI into diagnostics allowing for specific tailored treatments improving care given to patients with resultant better outcomes.
• Development of Novel Stents and Coils: Another crucial development in this market is the introduction of new stents and coils that are specifically made to treat brain aneurysms. These devices have been designed to be more flexible and able to cope with the intricate vascular system in the brain thereby improving their effectiveness even for previously non-operable aneurysms. The clinical trials are also underway for developing drug-eluting stents which release medicine into the patient to prevent reformation of the aneurysm. These advances present a wider range of treatment alternatives for patients, especially those with complex or high-risk aneurysms, resulting in better long-term outcomes.

Advancements in imaging technologies, minimally invasive procedures or AI integration have collectively revolutionized patient care in the brain aneurysm market. These innovations are leading to earlier detection, more effective treatments, and improved outcomes, which are crucial in managing the risks associated with brain aneurysms. Furthermore, growth of novel medical devices and emphasis on public awareness is enhancing the market further guaranteeing that more patients receive timely and appropriate care.

Strategic Growth Opportunities for Brain Aneurysm Market

Various applications offer several strategic growth opportunities within the brain aneurysm market as a result of technological advancements and increased demand for better diagnostics and therapies. The market is undergoing these changes through provisioning wider access to care increasing efficacy of treatments and promoting innovation.

• Endovascular Therapy Expansion: Growth of endovascular therapy is a tremendous opportunity in brain aneurysm market. As these minimally invasive procedures become more precise and accessible, they have the potential to be used more widely across health care settings. Endovascular coiling and flow diversion are increasingly being preferred as the treatment methods for numerous aneurysm cases because of their safety and efficacy. Expanding the availability of these therapies, particularly in emerging markets, could increase the number of patients who receive timely and appropriate care significantly, thus driving market growth.
• AI-Driven Diagnostic Tools: Developing and deploying AI-driven diagnostic tools offer a major growth opportunity in brain aneurysm market. Complex imaging data can now be analyzed by means of AI or machine learning algorithms to detect aneurisms with high precision even at early stages. Integrating those tools into clinical practice will enable healthcare providers to improve on diagnostic efficiency while reducing chances of misdiagnosing them. On top of that, AI tools are scalable such that they can be adopted in various healthcare set-ups ranging from big hospitals to small clinics hence enhancing accessibility to cutting-edge diagnostics capabilities which promote market expansion.
• Personalized Treatment Approaches: Critical growth areas in the brain aneurysm market are connected to individual treatment. This is via genetic testing and biomarker analysis that assist medical practitioners to customize their plans for the patients, consequently optimizing results while at the same time minimizing any risks. This way, there will be better placements of interventions, particularly for complex cases where common treatments have been found not effective. The more research on genetic and molecular basis of aneurysms that is done, the more chances of developing targeted therapies will open up hence significant market growth.
• Development of Advanced Medical Devices: Next generation stents and coils such as those under development represent a significant growth opportunity in the Brain Aneurysm market. They are designed to be more effective and easier touse resulting in better patient outcomes and expanding the number of cases amenable to minimally invasive techniques. Thus drug-eluting stents, bioresorbable coils, etc would turn out to be new therapeutic options. As they are launched into markets these devices are expected to boost sales by providing better answers to treating brain aneurysms

The strategic growth opportunities in the Brain Aneurysm market instigated by endovascular therapy advancements; AI diagnostics advancement; personalized medicine innovation as well as medical devices improvements have sparked path for immense market expansion. The increasing emphasis on screening and early detection furthers this development since more patients are being diagnosed and treated at earlier stages. They are thus expected to result in improved patient outcomes, expanded access to care and sustainable market growth over time.

Brain Aneurysm Market Driver and Challenges

The brain aneurysm market is impacted by a mixture of technological, economic and regulatory factors that both drive and challenge it. As such, these components help to shape the marketplace through improving diagnostic and treatment capacities as well as creating barriers that hamper continual growth and innovation.

The factors responsible for driving the brain aneurysm market include:

1. Improvements in Diagnosis and Treatment Technologies: Technological advancements remain important in the Brain Aneurysm market. The development of complex imaging techniques like 3D angiography and AI-supported diagnostic tools has greatly revolutionized early identification of brain aneurysms. This makes it possible to obtain earlier diagnoses that are more accurate enough for effective intervention. In addition, patient outcomes have been improved via innovative methods of treatment such as minimally invasive endovascular procedures, as well as newer stents/coils among others. These technology improvements increase overall care quality which impacts positively on the standard of care while expanding intervention choices available; this drives market growth.

2. Increasing Awareness and Early Detection: The brain aneurysm market is driven by raising awareness in the public domain as well as establishment of early detection programs. Awareness campaigns reduce the information deficit that exists among people concerning brain aneurysms, which in turn makes them seek medical attention faster. These programs promote early diagnosis especially for vulnerable populations thereby increasing chances of successful therapy. Such an approach is reactive with respect to a decline in ruptures and involved pathologies leading to better patient outcomes. Thus, as awareness and early detection efforts further increase, they are expected to stimulate further development within the market.

3. Rising Healthcare Expenditure and Investment: Another important factor driving the brain aneurysm market is rising healthcare expenditure and investment notably in advanced economies. Governmental organizations along with other private actors tend to invest more into healthcare infrastructure, researches and developments that provide patients with access to advanced diagnostic options. Additionally, funds that have been put forward will be useful when building modern clinics specially targeted at treating severe situations resulting from aneurysms. As a result, improved care has become available for more patients who are demanding treatment of a brain aneurysm; thus fueling this industry's growth rate.

Challenges in the brain aneurysm market are:

1. High Cost of Advanced Diagnostic and Treatment: The brain aneurysm market is faced with one of its main difficulties which are the high cost of advanced diagnostic and treatment options. Using cutting edge technologies such as 3D imaging, AI-driven diagnostics and minimally invasive procedures could come with a lot of money while preventing some patients from benefiting from them. In places where healthcare funding is limited or insurance coverage is inadequate, these expenses can be too high, thus leading to differences in access to medical care. This can be addressed by reducing costs through innovation, expanding insurance coverage and government support so that more people can access life-saving treatments.

2. Limited Access to Specialized Care: Another major challenge for the brain aneurysm market is difficulty in accessing specialized care especially in low-income countries or developing economies. Expertise and sophisticated equipment necessary for diagnosis and treatment of brain aneurysms are often concentrated in major urban areas thereby leaving those residing in remote parts or underserviced areas with minimal choice. This inequality of access may result in delays in diagnosis and treatment, increasing the risk of aneurysm rupture as well as complicating outcomes thereof. To overcome this hurdle there should be efforts to widen the reach of specialty care through telemedicine, training programs besides investing into healthcare infrastructure.

3. Regulatory and Approval Delays: Regulatory hitches and sanction delays have remained a major stumbling block in the Brain Aneurysm market. Although conducive regulatory environments can spur innovation, the process of approving new treatments and devices can be protracted and intricate. The slow adoption of these products to the market may lead to its limited supply and then with it more than a few patients would certainly remain without options for better treatment. At the same time, this may cause difficulties for start-ups dealing with regulation hence hampering their creativity. This challenge could be eased by finding ways to fast-track approvals as well as giving clearer directives that will make new technologies reach the market on time every day.

The brain aneurysm market is influenced by various driving forces and impediments that interact vividly. Market growth has been driven forward by technological advancements, raised awareness, increased healthcare spending and supportive regulatory environments leading to improved patient care and outcomes across globe. However, there are still some hurdles such as high prices, lack of specialized healthcare provision or regulation gaps that need to be addressed for maintaining sustainable development in this field.

List of Brain Aneurysm Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain aneurysm companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain aneurysm companies profiled in this report include-

• Pfizer
• F. Hoffmann-La Roche
• Mylan
• Fresenius Kabi
• Hikma Pharmaceuticals
• Novartis
• Teva Pharmaceutical Industries
• Heyer Medical
• Smiths Medical
• Johnson & Johnson Services

Brain Aneurysm by Segment

The study includes a forecast for the global brain aneurysm by type, treatment, route of administration, end use, and region.

Brain Aneurysm Market by Type [Analysis by Value from 2018 to 2030]:

• Ruptured Aneurysm
• Leaking Aneurysm
• Unruptured Aneurysm
• Others

Brain Aneurysm Market by Treatment [Analysis by Value from 2018 to 2030]:

• Surgery
• Medication
• Others

Brain Aneurysm Market by Route of Administration [Analysis by Value from 2018 to 2030]:

• Oral
• Parenteral
• Others

Brain Aneurysm Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Homecare
• Specialty Centres
• Others

Brain Aneurysm Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Brain Aneurysm Market

The progressions in the brain aneurysm industry in the United States, China, Germany, India and Japan leading to breakthroughs in diagnosis, treatment and care for patients are remarkable. These developments result from a combination of innovative technology, increased spending on healthcare as well as increase awareness about brain aneurysms. With these markets evolving they focus on improving early detection methods; embracing less invasive procedures and improving the health system infrastructure to handle and treat brain aneurysms better.

• United States: A surge in the use of advanced imaging technologies like 3D angiography and AI-assisted diagnostics has greatly improved accuracy levels of detecting brain aneurysms. There is also increased uptake of minimally invasive endovascular procedures that have led to improved patient outcomes with shorter recovery times. In addition ongoing clinical trials are assessing new therapies including novel stents designs and drug eluting devices. This progress is underpinned by strong collaborations between research institutions and biotech firms fostering innovation when it comes to treatment alternatives.
• China: The brain aneurysm market in China is experiencing rapid growth. This is attributed to the substantial government investment in healthcare infrastructure. The adoption of the latest diagnostic tools such as 3D imaging and AI-powered analysis has led to improvement in early detection rates. There is also increasing focus on training medical practitioners on minimally invasive surgical skills that result to better treatment outcomes. Awareness campaigns have increased leading to early diagnosis and intervention. Moreover, international collaborations are being witnessed within China which are facilitating transfer of advanced technologies and best practices.
• Germany: Germany's brain aneurysm market is marked by high investments in research and development (R&D), especially for endovascular therapy and neurosurgery. For instance, Germany has witnessed an increase in the number of hybrid operating rooms with state-of-the-art imaging facilities thereby enabling more accurate procedures at a minimally invasive nature. German hospitals also lead the world in terms of use of robotic-assisted surgery for enhancing precision during aneurysm treatments. Further, there's a growing emphasis on personalized medicine, where genetic testing becomes part of treatment planning that adjusts therapies based on specific needs of each patient.
• India: India's brain aneurysm market has been developing fast with improved access to healthcare and infrastructure. Advanced imaging like MRI and CT angiography is becoming more common, facilitating quick and accurate diagnosis. Neurosurgeon training also emphasizes minimally invasive methods that cut down the danger of complication and better patient' outcomes. In addition, government initiatives for brain aneurysm awareness are responsible for early treatment and detection. India's boom in pharmaceutical industry is instrumental in coming up with affordable therapies.
• Japan: Japan's investment in technology and innovation makes it one of the leading markets in Brain Aneurysm development. This includes progress in endovascular therapy involving new stent systems as well as embolization techniques. Moreover, Japan is among world leaders when it comes to use of AI and machine learning for predictive analytics on brain aneurysm diagnosis and management. Consequently, advanced imaging and surgical procedures have been increasingly adopted as the aging population demands efficient treatments requiring less invasiveness. Furthermore, Japan has a regulatory framework that assures swift approval of novel medical devices; hence fueling expansion within the market much faster than ever before.

Features of the Global Brain Aneurysm Market

Market Size Estimates: Brain aneurysm market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain aneurysm market size by various segments, such as by type, treatment, route of administration, end use, and region in terms of value ($B).

Regional Analysis: Brain aneurysm market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatment, route of administration, end uses, and regions for the brain aneurysm market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain aneurysm market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the growth forecast for brain aneurysm market?

Answer: The global brain aneurysm market is expected to grow with a CAGR of 8.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the brain aneurysm market?

Answer: The major drivers for this market are escalating occurrence of neurological disorders on a global scale and surge in aging population.

Q3. What are the major segments for brain aneurysm market?

Answer: The future of the brain aneurysm market looks promising with opportunities in the hospitals, homecare, and specialty centers markets.

Q4. Who are the key brain aneurysm market companies?

Answer: Some of the key brain aneurysm companies are as follows:

• Pfizer
• F. Hoffmann-La Roche
• Mylan
• Fresenius Kabi
• Hikma Pharmaceuticals
• Novartis
• Teva Pharmaceutical Industries
• Heyer Medical
• Smiths Medical
• Johnson & Johnson Services

Q5. Which brain aneurysm market segment will be the largest in future?

Answer: Lucintel forecasts that unruptured aneurysms will remain the largest segment over the forecast period.

Q6. In brain aneurysm market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing prevalence of brain injuries and high healthcare spending and insurance coverage in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain aneurysm market by type (ruptured aneurysm, leaking aneurysm, unruptured aneurysm, and others), treatment (surgery, medication, and others), route of administration (oral, parenteral, and others), end use (hospitals, homecare, specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Brain Aneurysm Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Brain Aneurysm Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Brain Aneurysm Market by Type
  • 3.3.1: Ruptured Aneurysm
  • 3.3.2: Leaking Aneurysm
  • 3.3.3: Unruptured Aneurysm
  • 3.3.4: Others
• 3.4: Global Brain Aneurysm Market by Treatment
  • 3.4.1: Surgery
  • 3.4.2: Medication
  • 3.4.3: Others
• 3.5: Global Brain Aneurysm Market by Route of Administration
  • 3.5.1: Oral
  • 3.5.2: Parenteral
  • 3.5.3: Others
• 3.6: Global Brain Aneurysm Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Specialty Centres
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Brain Aneurysm Market by Region
• 4.2: North American Brain Aneurysm Market
  • 4.2.1: North American Brain Aneurysm Market by Type: Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, and Others
  • 4.2.2: North American Brain Aneurysm Market by End Use: Hospitals, Homecare, Specialty Centres, and Others
• 4.3: European Brain Aneurysm Market
  • 4.3.1: European Brain Aneurysm Market by Type: Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, and Others
  • 4.3.2: European Brain Aneurysm Market by End Use: Hospitals, Homecare, Specialty Centres, and Others
• 4.4: APAC Brain Aneurysm Market
  • 4.4.1: APAC Brain Aneurysm Market by Type: Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, and Others
  • 4.4.2: APAC Brain Aneurysm Market by End Use: Hospitals, Homecare, Specialty Centres, and Others
• 4.5: ROW Brain Aneurysm Market
  • 4.5.1: ROW Brain Aneurysm Market by Type: Ruptured Aneurysm, Leaking Aneurysm, Unruptured Aneurysm, and Others
  • 4.5.2: ROW Brain Aneurysm Market by End Use: Hospitals, Homecare, Specialty Centres, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Aneurysm Market by Type
  • 6.1.2: Growth Opportunities for the Global Brain Aneurysm Market by Treatment
  • 6.1.3: Growth Opportunities for the Global Brain Aneurysm Market by Route of Administration
  • 6.1.4: Growth Opportunities for the Global Brain Aneurysm Market by End Use
  • 6.1.5: Growth Opportunities for the Global Brain Aneurysm Market by Region
• 6.2: Emerging Trends in the Global Brain Aneurysm Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Aneurysm Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Aneurysm Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: F. Hoffmann-La Roche
• 7.3: Mylan
• 7.4: Fresenius Kabi
• 7.5: Hikma Pharmaceuticals
• 7.6: Novartis
• 7.7: Teva Pharmaceutical Industries
• 7.8: HEYER Medical
• 7.9: Smiths Medical
• 7.10: Johnson & Johnson Services